Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manuka New Zealand is a specialized producer and distributor of high-quality monofloral Manuka honey and honey-based health products. The company focuses on the therapeutic applications of Methylglyoxal (MGO), a bioactive compound found in Manuka honey known for its potent antibacterial and anti-inflammatory properties. Their product portfolio includes medical-grade honey, supplements, and skincare treatments designed for wound care, digestive wellness, and immune system support. Manuka New Zealand operates a vertically integrated supply chain, ensuring rigorous testing and certification of their products from hive to consumer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Manuka New Zealand.